Medicale Corp. (MCLE) EBIT (2020 - 2025)

Medicale (MCLE) has reported EBIT for 6 consecutive years, with -$3144.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, EBIT rose 79.03% year-over-year to -$3144.0; the trailing twelve-month figure through Dec 2025 stood at -$21642.0 (up 57.06% YoY), and the FY2025 full-year result was -$33493.0, up 38.78% from the prior year.
• EBIT improved to -$3144.0 in Q4 2025 per MCLE's latest filing, from -$8654.0 in the prior quarter.
• Across five years, EBIT topped out at -$3144.0 in Q4 2025 and bottomed at -$19307.0 in Q4 2023.
• Historically, EBIT has averaged -$9679.7 across 5 years, with a median of -$8595.5 in 2023.
• The sharpest annual moves came in 2023 and 2025: EBIT slumped 121.56% in 2023, then surged 79.03% in 2025.
• Over 5 years, EBIT stood at -$18096.0 in 2021, then jumped by 51.85% to -$8714.0 in 2022, then slumped by 121.56% to -$19307.0 in 2023, then rose by 22.33% to -$14995.0 in 2024, then soared by 79.03% to -$3144.0 in 2025.
• According to Business Quant data, EBIT over the past three periods registered -$3144.0, -$8654.0, and -$3575.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.